Copyright
©The Author(s) 2019.
World J Hepatol. Feb 27, 2019; 11(2): 173-185
Published online Feb 27, 2019. doi: 10.4254/wjh.v11.i2.173
Published online Feb 27, 2019. doi: 10.4254/wjh.v11.i2.173
Experimental model | Animal species | Biological findings | Clinical Signs |
Portacaval anastomosis | Rats, dog, rabbit, pig | Increased brain ammonia/glutamine | Altered circadian cycle, hypokinesia, reduced memory and learning ability |
Congenital portacaval shunts | Dogs, cats | Hyperammonemia | Hepatic dysfunction, psychomotor dysfunction, motor signs |
Graded portal vein stenosis | Rats | Increased brain ammonia/glutamine | Minimal hepatic encephalopathy, loss of activity, altered circadian cycle |
Carbon tetrachloride (CCl4) | Rats, mice | Generation of free radicals, lipoperoxidation, tissue fibrosis, increased hepatic membrane permeability | Hepatic failure, motor activity dysfunction |
Bile duct ligation | Rats | Bacterial translocation, immune system dysfunction, hyperammonemia | Liver failure, portal hypertension, decreased locomotor activities due to low-grade encephalopathy |
- Citation: Lima LCD, Miranda AS, Ferreira RN, Rachid MA, Simões e Silva AC. Hepatic encephalopathy: Lessons from preclinical studies. World J Hepatol 2019; 11(2): 173-185
- URL: https://www.wjgnet.com/1948-5182/full/v11/i2/173.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i2.173